Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...
Nonoperative treatment, such physical therapy, is the typical approach to treating rotator-cuff tears. However, surgery is considered in certain patients whose rotator-cuff tears don't resolve with ...
Vertex Pharmaceuticals ( VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and ...
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Today is World Cancer Day, and many of us might be taking a look at our wellbeing. One woman who said she ignored four symptoms at first later found out she had an advanced form of breast cancer ...
About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...
16h
Canadian Prime Minister Justin Trudeau announced that Canada would respond with 25% tariffs "against $155 billion worth of ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...
Dr. Sterling Elliott, Clinical Pharmacist at Northwestern Medicine and Assistant Professor of Orthopedics at Feinberg School ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.
The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...
Jurors didn't find a drug dealer responsible for the deaths of his customers, but prosecutors urged a judge to send him to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback